---
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/36126017/
file_path: 2022/09/aspirin-use-to-prevent-cardiovascular-disease.md
issue: '3'
keywords:
- Humans
- Cardiovascular Diseases
- Platelet Aggregation Inhibitors
- Primary Prevention
- Aspirin
last_updated: '2025-07-30'
mesh_terms:
- Aspirin
- Cardiovascular Diseases
- Humans
- Platelet Aggregation Inhibitors
- Primary Prevention
original_format: PubMed
pages: Online
patient_population: Adults
peer_reviewed: true
pmid: '36126017'
processed_date: '2025-07-30'
publication_date: '2022-09-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Aspirin Use to Prevent Cardiovascular Disease.
topics:
- Family Medicine
volume: '106'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '36126017'
  title: Aspirin Use to Prevent Cardiovascular Disease.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '106'
    issue: '3'
  publication_info:
    year: '2022'
    month: 09
    full_date: '2022-09-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Aspirin
    major_topic: true
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: Cardiovascular Diseases
    major_topic: true
    qualifiers:
    - qualifier: prevention & control
      major_topic: false
  - descriptor: Humans
    major_topic: false
  - descriptor: Platelet Aggregation Inhibitors
    major_topic: false
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: Primary Prevention
    major_topic: false
  publication_types: *id001
related_articles:
- pmid: '36126017'
  title: Aspirin Use to Prevent Cardiovascular Disease.
  authors: []
  source: Am Fam Physician
  pubdate: 2022 Sep
- pmid: '21985953'
  title: Trials of primary prevention of cardiovascular events using aspirin.
  authors:
  - name: Kappagoda CT
    authtype: Author
    clusterid: ''
  - name: Amsterdam EA
    authtype: Author
    clusterid: ''
  source: Am J Cardiol
  pubdate: 2011 Oct 15
- pmid: '19726108'
  title: '[Aspirin and primary prevention of cardiovascular diseases in the elderly].'
  authors:
  - name: Manr√≠quez M
    authtype: Author
    clusterid: ''
  - name: Vallano A
    authtype: Author
    clusterid: ''
  source: Rev Esp Geriatr Gerontol
  pubdate: 2009 Nov-Dec
- pmid: '22669555'
  title: Aspirin for the primary prevention of cardiovascular diseases.
  authors:
  - name: Tagliabue L
    authtype: Author
    clusterid: ''
  - name: Dipaola F
    authtype: Author
    clusterid: ''
  - name: Perego F
    authtype: Author
    clusterid: ''
  - name: Podda GM
    authtype: Author
    clusterid: ''
  - name: Gruppo di Autoformazione Metodologica (GrAM)
    authtype: CollectiveName
    clusterid: ''
  source: Intern Emerg Med
  pubdate: 2012 Aug
- pmid: '22942227'
  title: Primary and secondary prevention of cardiovascular disease in diabetes with
    aspirin.
  authors:
  - name: Ajjan RA
    authtype: Author
    clusterid: ''
  source: Diab Vasc Dis Res
  pubdate: 2012 Oct
---

# Aspirin Use to Prevent Cardiovascular Disease.

**Published in:** American family physician | Vol. 106, No. 3 | 2022-09-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/36126017/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Aspirin, Cardiovascular Diseases, Humans, Platelet Aggregation Inhibitors, Primary Prevention

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/36126017/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
